CollPlant Biotechnologies CLGN
NASDAQ CLGN
$3.80 -0.07 (-1.81%)
As of: Sep 29, 2026 · 3:59 PM EDT

CollPlant Biotechnologies (CLGN) Common Equity (2017 - 2025)

Updated

CollPlant Biotechnologies (CLGN) posted Common Equity of $6.08 million for the quarter ended Dec 31, 2025, down 54.8% from $13.47 million a year earlier and down 34.6% from the prior quarter.

Analysis

CollPlant Biotechnologies (CLGN) Common Equity (2017 - 2025) Analysis & Trends

Since the quarter ended Dec 31, 2017, CollPlant Biotechnologies has reported Common Equity for 31 quarters.

  • Annual Common Equity has declined for four consecutive years, though with a five-year compound annual growth rate of 6.3% (years ended Dec 2020 to Dec 2025).
  • In prior years, CollPlant Biotechnologies' Common Equity was $13.47 million in the year ended Dec 31, 2024 (-52.5%), $28.34 million in the year ended Dec 31, 2023 (-12.2%), $32.28 million in the year ended Dec 31, 2022 (-28.5%) and $45.12 million in the year ended Dec 31, 2021 (+907.8%).
  • The figure for the quarter ended Dec 31, 2025 stands as the lowest quarterly Common Equity since the quarter ended Dec 31, 2020.
  • On a year-over-year basis, Common Equity has declined in each of the last three quarters, with an average decline of 42.9% over the last seven quarters.
  • The strongest year-over-year quarter for Common Equity in the past five years was the quarter ended Dec 31, 2021, with growth of 907.8%; the weakest was the quarter ended Dec 31, 2025, with a decline of 54.8%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 CollPlant Biotechnologies 4.95 Mn 4.95 Mn -243,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.08 Mn
Sep 30, 2025 9.31 Mn
Jun 30, 2025 12.51 Mn
Dec 31, 2024 13.47 Mn
Sep 30, 2024 16.92 Mn
Jun 30, 2024 20.73 Mn
Mar 31, 2024 24.45 Mn
Dec 31, 2023 28.34 Mn
Sep 30, 2023 32.40 Mn
Jun 30, 2023 36.04 Mn
Mar 31, 2023 29.89 Mn
Dec 31, 2022 32.28 Mn
Sep 30, 2022 35.81 Mn
Jun 30, 2022 39.51 Mn
Mar 31, 2022 43.20 Mn
Dec 31, 2021 45.12 Mn
Sep 30, 2021 48.48 Mn
Jun 30, 2021 49.44 Mn
Mar 31, 2021 50.65 Mn
Dec 31, 2020 4.48 Mn
API Access

CollPlant Biotechnologies Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CLGN&period=max&api_key=YOUR_API_KEY